eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neurofibromatosis 2 |
| Symptom | C0027859|vestibular schwannoma |
| Sentences | 11 |
| PubMedID- 24335931 | Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. |
| PubMedID- 21817944 | Objectives: to discuss our management strategy of vestibular schwannoma in patients with neurofibromatosis type 2 (nf2). |
| PubMedID- 24436903 | Six patients had neurofibromatosis type 2 (nf2) with bilateral vestibular schwannomas and meningiomas, and the four others had aggressive recurrent meningiomas. |
| PubMedID- 24311643 | Methods: we conducted a single-institution, prospective, 2-stage, open-label phase ii study to estimate the response rate to everolimus in neurofibromatosis type 2 (nf2) patients with progressive vestibular schwannoma (vs). |
| PubMedID- 25537817 | The aim of this study was to evaluate the cochlear implant (ci) performances in neurofibromatosis type 2 (nf2) patients with bilateral vestibular schwannoma (vs) and in patients with sporadic vs in the only or better hearing ear. |
| PubMedID- 26287269 | Factors influencing the growth rate of vestibular schwannoma in patients with neurofibromatosis type 2. |
| PubMedID- 25567352 | Phase ii study of mtorc1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas. |
| PubMedID- 20848106 | Furthermore, tumour location and patient age may point to a familial tumour syndrome as in the case of neurofibromatosis type 2 (nf2) with typical bilateral vestibular schwannoma in young age. |
| PubMedID- 22844108 | This single-institution phase ii study was performed to estimate the response rate to lapatinib in neurofibromatosis type 2 (nf2) patients with progressive vestibular schwannoma (vs). |
| PubMedID- 22805104 | Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. |
| PubMedID- 26108240 | Bevacizumab treatment for vestibular schwannoma in a patient with neurofibromatosis type 2: hearing improvement and tumor shrinkage. |
Page: 1